Side effects or complications-Motor fluctuations Posts on Medivizor

Posted by Medivizor on Sep 17, 2023 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa (ABBV-951) for the treatment of motor fluctuations in patients with Parkinson’s disease (PD). The data showed that continuous subcutaneous foslevodopa-foscarbidopa significantly improved motor fluctuations in these patients. Some...

Posted by Medivizor on Dec 5, 2021 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of the ND0612 delivery system of levodopa/carbidopa (Sinemet) in patients with Parkinson's disease (PD). The authors showed that the system was well-tolerated and safe and that it reduced the fluctuations of the levodopa plasma levels.  Some background Parkinson's...

Posted by Medivizor on Mar 21, 2021 in Parkinson's Disease | 0 comments

In a nutshell This study reviewed the effectiveness and safety of tolcapone (Tasmar) in treating patients with Parkinson’s disease (PD). Researchers suggested that tolcapone might be a good and safe option for the treatment of these patients. Some background PD affects the brain cells which control body functions. These cells lose their...

Posted by Medivizor on Feb 21, 2020 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the safety and effectiveness of CVT-301 (Inbrija) for the treatment of wearing-off symptoms in patients with Parkinson's disease. Researchers suggested that this treatment was effective in improving off periods with no significant differences in side effects compared to standard levodopa. Some background...

Posted by Medivizor on Dec 31, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of sublingual apomorphine (Apokyn) in the treatment of off times in patients with Parkinson's disease. Researchers suggested that this treatment might be a safe and effective option for the treatment of these patients. Some background Parkinson's disease (PD) is the second most...

Posted by Medivizor on Jun 30, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of a new carbidopa–levodopa treatment for patients with Parkinson's disease. Researchers suggested that this treatment is associated with a better control of the symptoms. Some background Nearly one million people will have Parkinson's disease (PD) in the US by 2020. This disease...

Posted by Medivizor on Jun 16, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of Gocovri (amantadine) in the treatment of dyskinesia (DYS) in patients with Parkinson's disease (PD). Researchers suggested that this treatment improves DYS symptoms. Some background PD affects brain cells. The abilities controlled by these cells are lost, such as muscle function and...